Google’s Moon Shot
The vast majority of books [Google is publishing online] belong to a third category: still protected by copyright, or of uncertain status, and out of print. These books are at [...]
The vast majority of books [Google is publishing online] belong to a third category: still protected by copyright, or of uncertain status, and out of print. These books are at [...]
Since 2003, EFF has championed an alternative approach that gets artists paid while making file sharing legal: voluntary collective licensing. The concept is simple: the music industry forms several "collecting [...]
[M]ost copyrighted works have a short commercial life. Only a tiny fraction of books, songs, movies, and software are so successful that they enjoy multiple printings and continue to sell [...]
On September 8, 2003, the recording industry sued 261 American music fans for sharing songs on peer-to-peer (P2P) file sharing networks, kicking off an unprecedented legal campaign against the people [...]
Why do firms in some industries ignore patents when developing new products? This paper posits a simple answer to this long puzzling question: firms ignore patents because they are unable [...]
This wasn’t the first time the DMCA had interfered with my security research. Back in 2001, my colleagues and I had had to withdraw a peer-reviewed paper about CD copy [...]
This article presents an econometric analysis of the direct effects of the R&D tax credit (RTC) on private R&D investment and capital in France and proposes an ex ante evaluation [...]
Proponents of stronger copyright terms have argued that stronger copyright terms encourage creativity by increasing the profitability of authorship. Empirical evidence, however, is scarce, because data on the profitability of [...]
In most areas of the law, we try to avoid this kind of unfairness [in payouts from civil litigation] and uncertainty by making sure that we tie penalties to the [...]
We examine the impact of loss of U.S. patent exclusivity (LOE) on the prices and utilization of specialty drugs between 2001 and 2007. We limit our empirical cohort to drugs [...]